(Whitney Curtis/AP Images for Mallinckrodt, File)

Generic opiate manufacturer Mallinckrodt and its creditors are moving closer to a deal that would provide opioid victims with a $250 million one-time payment, in a move that would leave them with $1 billion less than they were promised last year.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Employee Participation
Employer-Paid